E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/23/2005 in the Prospect News Biotech Daily.

SFBC still hold, Jefferies says

SFBC International Inc. was maintained by Jefferies & Co. Inc. analyst David Windley at a hold rating after a meeting with management and tour of the facilities allowed for more perspective. Valuation remains low and a comment about "pursuing strategic alternatives" should raise some antennae, but Jefferies said it believes it's still too early to assume business losses are contained. Shares of the Miami drug development services company were up 95 cents, or 6.01%, at $16.77 on volume of 2,103,404 shares versus the three-month running average of 2,020,220 shares.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.